| |
|
有賀 悦子 |
帝京大学医学部緩和医療学講座・教授 |
| 緩和医療学 |
| Matsuo N, Morita T, Matsuda Y, Okamoto K, Matsumoto Y, Kaneishi K, Odagiri T, Sakurai H, Katayama H, Mori I, Yamada H, Watanabe H, Yokoyama T, Yamaguchi T, Nishi T, Shirado A, Hiramoto S, Watanabe T, Kohara H, Shimoyama S, Aruga E, Baba M, Sumita K, Iwase S. Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study. J Pain Symptom Manage. 52(1): 64-72, 2016 |
| Sasahara T, Watakabe A, Aruga E, Fujimoto K, Higashi K, Hisahara K, Hori N, Ikenaga M, Izawa T, Kanai Y, Kinoshita H, Kobayakawa M, Kobayashi K, Kohara H, Namba M, Nozaki-Taguchi N, Osaka I, Saito M, Sekine R, Shinjo T, Suga A, Tokuno Y, Yamamoto R, Yomiya K, Morita T. Assessment of Reasons for Referral and Activities of Hospital Palliative Care Teams Using a Standard Format. A Multicenter 1000 Case Description. Journal of pain and symptom management. 47(3): 579-587.e6, 2013 |
| Aruga E, Tanigawa K, Aruga A, Arai H, Smith II JW, Nickoloff BJ, Nabel GJ and Chang AE; CD95-Mediated Tumor Recognition by CD4+ Effecor Cells in a Murine Mammary Model. J of Immunother, 23(29): 225-234, 2000 |
|
| |
|
北川 雄光 |
慶應義塾大学外科学教授 |
| 外科 |
| Nagahashi M, Wakai T, Shimada Y, Ichikawa H, Kameyama H, Kobayashi T, Sakata J, Yagi R, Sato N, Kitagawa Y, Uetake H, Yoshida K, Oki E, Kudo SE, Izutsu H, Kodama K, Nakada M, Tse J, Russell M, Heyer J, Powers W, Sun R, Ring JE, Takabe K, Protopopov A, Ling Y, Okuda S, Lyle S. Genomic landscape of colorectal cancer in Japan: Clinical implications of comprehensive genomic sequencing for precision medicine. Genome Med 8(136): , 2016.12 |
| Akutsu Y, Kato, K, Igaki H, Ito Y, Nozaki I, Daiko H, Yano M, Udagawa H, Nakagawa S, Takagi M, Mizusawa J, Kitagawa Y. The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study. Ann Surg 246(6): 1009-1015, 2016.12 |
Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Nagai Y, Asami C, Kitagawa Y. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer 115(11): 1328-1334, 2016.11
|
|
| |
|
小西 郁生 |
国立病院機構 京都医療センター・院長 |
| 産科婦人科学（婦人科腫瘍学） |
Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M.
Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
Oncotarget 7:54758-54770, 2016.
|
Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M.
Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.
Oncotarget 7:47620-47636, 2016.
|
Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I.
Establishment of a novel nistopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes.
Am J Pathol 186:1103-1113, 2016.
|
|
| |
|
坂元 昇 |
川崎市健康福祉局医務監 |
| 公衆衛生 |
| 大気汚染と健康被害への再考-川崎市における40年間にわたる気管支喘息罹患率と大気汚染物質濃度との経年推移の比較研究、坂元昇 日本職業・環境アレルギー学会雑誌 2014 21：33−44、 |
| 首都直下地震や南海トラフ巨大地震における公衆衛生活動DHEATの創設と災害医療コーディネーターとの連携の重要性、坂元昇 J. J. Disast. Med. 2016; 21:91-105 |
| The Human Basal Forebrain, Part I. An Overview The Primate Nervous System, Part III N. Sakamoto, L.Heimer,J.S. De OLMOS, G.F. Alheid, J. Pearson, K. Shinoda, A. Bjorklund, T. Hokfelt edt. Elsevier New York, 1-56 1999 |
|
| |
|
祖父江 友孝 |
大阪大学大学院医学系研究科・教授 |
| 専門分野 |
| Sobue T, Suzuki T, Naruke T. A case-control study for evaluating lung-cancer screening in Japan. Int J Cancer, 50: 230-7, 1992. |
| Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association Project. J Clin Oncol, 20: 911-20, 2002. |
| Sobue T, Yamamoto S, Hara M, Sasazuki S, Sasaki S, Tsugane S, JPHC Study Group. Japanese Public Health Center. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int. J. Cancer, 99: 245-251, 2002. |
|
| ○ |
|
中釜 斉 |
国立がん研究センター 理事長・総長 |
| 専門分野 |
| Kanemoto K, Fukuta K, Kawai N, Tozawa K, Ochiai M, Okamoto K, Ohnami S, Sakamoto H, Yoshida T, Kanai Y, Katoh M, Yasui T, Kohri K, Kakizoe T, Nakagama H. Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype. PLoS One, 11(11):e0167374, 2016. |
Yachida S, Wood LD, Suzuki M, Takai E, Totoki Y, Kato M, Luchini C, Arai Y, Nakamura H, Hama N, Elzawahry A, Hosoda F, Shirota T, Morimoto N, Hori K, Funazaki J, Tanaka H, Morizane C, Okusaka T, Nara S, Shimada K, Hiraoka N, Taniguchi H, Higuchi R, Oshima M, Okano K, Hirono S, Mizuma M, Arihiro K, Yamamoto M, Unno M, Yamaue H, Weiss MJ, Wolfgang CL, Furukawa T, Nakagama H, Vogelstein B, Kiyono T, Hruban RH, Shibata T. Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. Cancer Cell, 29(2):229-40, 2016
|
| Ishiguro T, Sato A, Ohata H, Ikarashi Y, Takahashi RU, Ochiya T, Yoshida M, Tsuda H, Onda T, Kato T, Kasamatsu T, Enomoto T, Tanaka K, Nakagama H, Okamoto K. Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. Cancer Res, 76(1):150-160, 2016 |
|
| |
|
梛野 正人 |
名古屋大学大学院医学系研究科腫瘍外科・教授 |
| 消化器外科（肝胆膵外科） |
| Anatomic features of independent right posterior portal vein variants: implication for left hepatic trisectionectomy. Watanabe N, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Surgery 161:347-345, 2016. |
| Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinoma. Tsukahara T, Ebata T, Shimoyama Y, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Ann Surg 266:126-132, 2016. |
| Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Surgery 161:394-404, 2016. |
|
| |
|
野田 哲生 |
公益財団法人がん研究会
代表理事・常務理事 がん研究所 所長
|
| 分子遺伝学 |
| H. Takeshima, M. Iino, H. Takekura, M. Nishi, J. Kuno, O. Minowa, H. Takano and T. Noda. (1994) Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature, 369: 556-559. |
| H. Shibata, K. Toyama, H. Shioya, M. Ito, M. Hirota, S. Hasegawa, H. Matsumoto, H. Takano, T. Akiyama, K. Toyoshima, R. Kanamaru, Y. Kanegae, I. Saito, Y. Nakamura, K. Shiba and T. Noda. (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 278: 120-123. |
| R. Yao, Y. Kondoh, Y. Natsume, H. Yamanaka, M. Inoue, H. Toki, R. Takagi, T. Shimizu, T. Yamori, H. Osada and T. Noda. (2014) A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells. Oncogene, 33: 4242-4252. |
|
| |
|
眞島 喜幸 |
特定非営利活動法人パンキャンジャパン 理事長 |
| 患者アドボカシー、がん研究支援 |
| がん政策研究の分野に関わる業績なし |
|
